Amarin Corporation PLC Stock News

During this health crisis, some companies sought the use of alternative sanitation ingredients like ethanol, isopropanol and methanol in making hand sanitizers.

On Monday,  shares of Amarin Corporation plc (NASDAQ:AMRN) reached at $7.05 price level during last trade its distance from 20 days simple moving average was [...]

Remdesivir is the only USFDA approved emergency use authorization treatment in severe (hospitalised) Covid-19 patients.

Hetero's generic version of Remdesivir will be marketed under the brand name 'Covifor' in India. The drug will be priced at around Rs 5,000 per dose.

Domestic pharma firm Glenmark Pharmaceuticals had on Saturday launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price

Drug firm Hetero on Sunday said it has received approval from regulator DCGI to launch investigational antiviral drug Remdesivir for the treatment of COVID-19.The company has received the manufacturin

MOSCOW (NYTIMES) - When you enter a home in Moscow, you take off your shoes. When you go to a play, you have to check your coat. When you eat a burger, you often wear gloves.. Read more at straitstime

Pharma major Dr Reddy's Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market.

Cadila has also been working on a DNA vaccine to fight Covid-19, which is currently in the animal testing stage

"Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Fingolimod Capsules, 0.5 mg, the generic version of Gilenya capsules, 0

The capsules are used in the treatment of adult patients with relapsing forms of multiple sclerosis

Glenmark's current portfolio consists of 164 products authorised for distribution in the US marketplace and 44 abbreviated new drug applications pending approval with the USFDA

Drug major Glenmark Pharmaceuticals on Friday said it has received final nod from the health regulator for Fingolimod capsules.

2020 may have witnessed skyrocketing rallies for some biotechs, but it most certainly hasn’t been kind to Amarin (AMRN).Shares are down by a gut wrenching 68% since the turn of the year. The one-tri